Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?-Reference-Cited by-同舟云学术

Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?

Published:2023-02-01 Issue:2 Volume:16 Page:101-107
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Müller Thomas¹^ORCID,Riederer Peter²,Kuhn Wilfried³

Affiliation:

1. Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Gartenstr. 1, 13088, Berlin, Germany

2. Center of Mental Health, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Füchsleinstrasse 15, 97080, Würzburg, Germany

3. Department of Neurology, Leopoldina Hospital Schweinfurt, Gustav Adolf Str. 8, 97422, Schweinfurt, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2176301

Reference82 articles.

1. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

2. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis

3. Parosmia post COVID-19: an unpleasant manifestation of long COVID syndrome

4. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 and cognitive impairment: From evidence to SARS‐CoV‐2 mechanism;Brain‐X;2024-04-16

2. Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment;Frontiers in Neurology;2024-04-04

3. Assessing the Impact of Agents with Antiviral Activities on Transmembrane Ionic Currents: Exploring Possible Unintended Actions;Biophysica;2024-03-27

4. Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment;GeroScience;2024-03-08

5. Molecular cross-talk between long COVID-19 and Alzheimer’s disease;GeroScience;2024-02-23